NASDAQ:ACXP | Free Cash Flow | Acurx Pharmaceuticals, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$1.41M
2025-12-31-$1.18M
2025-03-31-$2.05M
2024-12-31-$2.25M
2024-03-31-$3.06M
2023-12-31-$4.2M
2023-03-31-$1.93M
2022-12-31-$1.5M
2022-03-31-$1.88M
2021-12-31-$1.5M
2021-03-31-$547,138.00
2020-12-31-$959,754.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$6.79M
2024-12-31-$10.38M
2023-12-31-$9.8M
2022-12-31-$7.54M
2021-12-31-$5.01M
2020-12-31-$3.35M